The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert about a suspected ...
The National Agency for Food and Drug Administration and Control (NAFDAC) warns the public against counterfeit cancer drugs Phesgo® 600mg ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today provided a financial update, reiterating full ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has notified Nigerians, including healthcare ...
NAFDAC has alerted healthcare providers and the public about a suspected counterfeit batch of Phesgo 600mg/600mg/10ml ...
Analyst Jason Butler of JMP Securities reiterated a Buy rating on Halozyme (HALO – Research Report), retaining the price target of $73.00.Stay ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent alert to healthcare providers ...
Daily Post Nigeria on MSN3d
NAFDAC alerts Nigerians on fake cancer treatment drugsThe National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be wary of counterfeit cancer treatment drugs, Phesgo, in circulation.
NAFDAC, has issued an alert to healthcare professionals and the public regarding a suspected counterfeit batch of drug.
NAFDAC has warned of a counterfeit Phesgo 600mg/600mg/10ml cancer drug batch, confirming fake labels, tampering, and an invalid batch number.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback